Regeneron Pharmaceuticals received accelerated FDA approval for a drug and partnered with Onco360.
1 report, 1 independent
Updated Aug 5
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Regeneron Pharmaceuticals received accelerated FDA approval for a drug and partnered with Onco360.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Food and Drug Administration
government organization in Nonthaburi, Thailand
-
Regeneron Pharmaceuticals
American pharmaceutical company
Coverage
Newest first; wire copies grouped- GlobeNewswireOnco360® Has Been Selected as a Specialty Pharmacy Partner for LYNOZYFIC™ (linvoseltamab-gcpt) LOUISVILLE, Ky., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty